The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation
Open accessAbstract
Summary Receptor-interacting kinase-3 (RIPK3) is an activator of necroptotic cell death, but recent work has implicated additional roles for RIPK3 in inflammatory signaling independent of cell death. However, while necroptosis has been shown to contribute to antiviral immunity, death-independent roles for RIPK3 in host defense have not been demonstrated. Using a mouse model of West Nile virus (WNV) encephalitis, we show that RIPK3 restricts WNV pathogenesis independently of cell death. Ripk3−/− mice exhibited enhanced mortality compared to WT controls, while mice lacking the necroptotic effector MLKL, or both MLKL and caspase-8, were unaffected. The enhanced susceptibility of Ripk3−/− mice arose from suppressed neuronal chemokine expression and decreased central nervous system (CNS) recruitment of T lymphocytes and inflammatory myeloid cells, while peripheral immunity remained intact. These data identify pleiotropic functions for RIPK3 in the restriction of viral pathogenesis, and implicate RIPK3 as a key coordinator of immune responses within the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435 · cited 3×
“MLKL serves as an executioner protein, promoting cell death via plasma membrane disruption and cell rupture (Cho et al., 2009; Wang et al., 2014a).”
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059 · cited 1×
“…Cell (2017), http://dx.doi.org/10.1016/j.cell.2017.03.011 Please cite this article in press as: Daniels et al., RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation, Cell (2017), http://dx.doi.org/10.1016/j.cell.2017.03.011 Necrostatin-1 (Nec) (Degterev et al., 2008).”
InfluentialThe Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220 · cited 2×
“Ripk3 / (Newton et al., 2004), Mlkl / (Murphy et al., 2013), Casp8 / (Beisner et al., 2005), Mlkl / Casp8 / , RIPK1KD/KD (Berger et al., 2014), and RIPK3-2xFVfl/fl Mox2-Cre+ mice in this study were bred and housed under specific-pathogen free conditions at the University of Washington.”
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., & Mocarski, E. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462341 · Cited by 959 · cited 1×
“Activation of RIPK3 can occur downstream of diverse toll-like receptors (TLRs), via both TRIF and Myd88-dependent pathways (He et al., 2011; Kaiser et al., 2013).”
Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758 · cited 2×
“…signaling has been implicated in the control of diverse viral infections, including influenza A virus (IAV) (Nogusa et al., 2016), Vaccinia virus (Cho et al., 2009; Pan et al., 2014), herpes simplex virus-1 (HSV-1) (Huang et al., 2015), and murine cytomegalovirus (MCMV) (Upton et al., 2010, 2012).”
A complement–microglial axis drives synapse loss during virus-induced memory impairment
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D. K., et al. (2016) · Nature · doi:10.1038/nature18283 · Cited by 671
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606 · cited 2×
“For example, in contrast with recent reports using cultured myeloid cells (Ito et al., 2016), in neurons we observed that the requirement for RIPK1 and RIPK3 kinase activity downstream of TLR ligation did not require inhibition of the caspases.”
Virus Inhibition of RIP3-Dependent Necrosis
Upton, J. W., Kaiser, W. J., & Mocarski, E. S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.006 · Cited by 559 · cited 2×
“…signaling has been implicated in the control of diverse viral infections, including influenza A virus (IAV) (Nogusa et al., 2016), Vaccinia virus (Cho et al., 2009; Pan et al., 2014), herpes simplex virus-1 (HSV-1) (Huang et al., 2015), and murine cytomegalovirus (MCMV) (Upton et al., 2010, 2012).”
Activation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.051 · Cited by 526 · cited 1×
“RIPK3 is also expressed in glia, including microglia, astrocytes, and oligodendrocytes, where it has been shown to contribute to the pathogenesis of rodent and human neurodegeneration, CNS autoimmunity, and demyelination (Ito et al., 2016; Ofengeim et al., 2015; Re et al., 2014).”
Takahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J. B., Goossens, V, Roelandt, R., Van Hauwermeiren, F., Libert, C., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.176 · Cited by 465
Cited by
The Coming Decade of Cell Death Research: Five Riddles
Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.04.024 · Cited by 566
Necroptosis: a crucial pathogenic mediator of human disease
Choi, M. E., Price, D. R., Ryter, S. W., & Choi, A. M. K. (2019) · JCI Insight · doi:10.1172/jci.insight.128834 · Cited by 419
Targeting RIPK1 for the treatment of human diseases
Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 408
Snyder, A. G., Hubbard, N. W., Messmer, M. N., Kofman, S. B., Hagan, C. E., Orozco, S. L., Chiang, K., Daniels, B. P., Baker, D., & Oberst, A. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw2004 · Cited by 374
Self-citationLife, death, and autophagy in cancer: NF-κB turns up everywhere
Verzella, D., Pescatore, A., Capece, D., Vecchiotti, D., Ursini, M. V., Franzoso, G., Alesse, E., & Zazzeroni, F. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2399-y · Cited by 344
Necroptosis in the Pathophysiology of Disease
Khoury, M. K., Gupta, K., Franco, S. R., & Liu, B. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.10.012 · Cited by 323
Daniels, B. P., Kofman, S. B., Smith, J. R., Norris, G. T., Snyder, A. G., Kolb, J. P., Gao, X., Locasale, J. W., Martinez, J., Gale, M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.017 · Cited by 307
Self-citationHow neutrophils meet their end
Lawrence, S. M., Corriden, R., & Nizet, V. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.008 · Cited by 144
Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation
Woo, M. S., Ufer, F., Rothammer, N., Di Liberto, G., Binkle, L., Haferkamp, U., Sonner, J. K., Engler, J. B., Hornig, S., Bauer, S., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201290 · Cited by 56
Metadata
- Authors
- Daniels, B. P., Snyder, A. G., Olsen, T. M., Orozco, S., Oguin, T. H., Tait, S. W. G., Martinez, J., Gale, M., Loo, Y.-M., & Oberst, A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 169
- Issue
- 2
- Pages
- 301-313.e11
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2600098707
- Cited by
- 177
- References
- 15
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.